BRYNJELSEN SEAN
ETONBRYNJELSEN SEAN serves as director, officer: President & CEO at Eton Pharmaceuticals, Inc. (ETON). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
BRYNJELSEN SEAN's Insider Trading at Eton Pharmaceuticals, Inc. (ETON)
Buys
3 · $94.0K
Sells
4 · $7.61M
Total Shares Bought
25,000
Total Shares Sold
341,747
Related Insiders
Opaleye Management Inc.
10 percent owner
ETONSell · Jul 7, 2026
Jennifer McKie Adams
director
ETONSell · Jun 17, 2026
David Krempa
officer: Chief Business Officer
ETONSell · May 27, 2026
RIEDEL NORBERT G
Director
ETONSell · Feb 3, 2026
James R. Gruber
Chief Financial Officer
ETONSell · Jan 12, 2026
Ipek Erdogan-Trinkaus
Chief Commercial Officer
ETONSell · Dec 11, 2025